Eli Lilly’s Mounjaro Overtakes Novo Nordisk’s Wegovy in UK Market Leadership
Eli Lilly’s Mounjaro has emerged as the leading choice in the UK’s private obesity drug market, outperforming Novo Nordisk’s Wegovy…
UK Market
Read More
December 7, 2025
- ASG Eye Hospital to invest ₹2,000 crore to boost Nationwide Eye Care Access
- Gates Foundation Grants ₹1.3 Crore to Gujarat Biotechnology University for Pioneering Women’s Health Research
- Novo Nordisk to Introduce Ozempic in India This Month
- Uranium Traces Found in Breastmilk Across Bihar; Researchers Flag Possible Infant Health Risks